Related Experiment Video

Updated: Jun 4, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Achieving optimal lipid values in patients with dyslipidemia is associated with reduced risk of cardiovascular events

Scott L Charland1, Mark J Cziraky, Ralph Quimbo

  • 1University of Colorado, School of Pharmacy, Denver, CO, USA.

Journal of Clinical Lipidology
|February 5, 2011
PubMed

Insights

Achieving target levels for low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) significantly reduces cardiovascular (CV) event risk. This benefit is most pronounced in patients with multiple baseline lipid abnormalities.

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Preventive Cardiology

Background:

  • Cardiovascular (CV) event risk is linked to lipid levels, with combined optimal levels of low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) associated with lower risk.
  • However, the impact of achieving these combined lipid goals across different baseline lipid abnormality patterns remains under-investigated.

Purpose of the Study:

  • To assess the association between achieving target combined lipid values and the risk of CV events.
  • To analyze this association within distinct patient groups defined by their baseline lipid profiles.

Main Methods:

  • A retrospective analysis of a managed care database involving treatment-naïve adults at elevated CV risk.
  • Patients were categorized into three baseline cohorts: isolated high LDL-C, high LDL-C with low HDL-C or high TG, and high LDL-C with low HDL-C and high TG.
  • CV event risk was evaluated based on the achievement of combined desired lipid values within each cohort.

Main Results:

  • Achievement rates for combined desired lipid values varied by cohort: 29% in 385 days (Cohort 1), 11% in 413 days (Cohort 2), and 7% in 505 days (Cohort 3).
  • Achieving combined desired lipid values was associated with a significant reduction in CV event risk: 25% in Cohort 1, 46% in Cohort 2, and 46% in Cohort 3.
  • The adjusted hazards ratios for CV events were 0.75 (Cohort 1), 0.54 (Cohort 2), and 0.54 (Cohort 3).

Conclusions:

  • Patients reaching combined desired lipid values experienced a lower risk of CV events compared to those who did not.
  • The greatest risk reduction was observed in patients with multiple baseline lipid abnormalities (low HDL-C and/or high TG alongside high LDL-C).
  • These findings suggest that interventions addressing low HDL-C and/or high TG, in addition to high LDL-C, may offer substantial benefits for CV event prevention.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...